Emerald Mutual Fund Advisers Trust’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-118,715	Closed	-$2.23M	–	257
2020 Q4	$2.23M	Sell	118,715 -222,568	-65%	-$4.8M	0.08%	149
2020 Q3	$7.2M	Buy	341,283 +43,496	+15%	+$1.02M	0.32%	88
2020 Q2	$8.6M	Buy	297,787 +97,494	+49%	+$2.94M	0.41%	88
2020 Q1	$7.01M	Sell	200,293 -169,913	-46%	-$5.5M	0.44%	80
2019 Q4	$9.05M	Buy	+370,206	New	+$6.5M	0.37%	97

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's OYST Position: Q1 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2021, closing a stake of 118,715 shares — an estimated $2.23M sold.

Emerald Mutual Fund Advisers Trust first reported a position in OYST in Q4 2019 and held it in 5 quarters. The position peaked at $9.05M in Q4 2019. 61 funds tracked by Wall St. Rank hold OYST as of Q1 2021.

Emerald Mutual Fund Advisers Trust reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 118,715 Oyster Point Pharma, Inc. Common Stock shares in Q1 2021, an estimated $2.23M.
Emerald Mutual Fund Advisers Trust first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Emerald Mutual Fund Advisers Trust's Oyster Point Pharma, Inc. Common Stock position peaked at $9.05M in Q4 2019.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2021, filed 29 Apr 2021.